Wednesday, July 29, 2020

BioTheryX Finds $35M More

San Diego-based BioTheryX, a biotechnology company focused on protein modulation, has raised $35M in a Series D funding, the company said on Tuesday. The funding was led by MSD Partners, L.P. According to the company, Robert Platek, a Partner and Portfolio Manager at MSD Partners L.P., will be joining the company's Board of Directors. BioTheryx says is

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.